Chung is a resident at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York.
Management of hormone-naïve oligometastatic prostate cancer
Growing evidence supports the existence of an intermediate metastatic disease state.
Darolutamide plus ADT approved in EU for mHSPC
Mitomycin intravesical solution demonstrates long-term durability in LG-IR-NMIBC
Experts urge FDA to remove black box warning on low-dose vaginal estrogen
Phase 3 TALAPRO-2 data of talazoparib plus enzalutamide published in The Lancet